Amundi Makes New $271,000 Investment in Hawkins, Inc. (NASDAQ:HWKN)

Amundi purchased a new position in shares of Hawkins, Inc. (NASDAQ:HWKNFree Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,293 shares of the specialty chemicals company’s stock, valued at approximately $271,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Jane Street Group LLC increased its stake in Hawkins by 127.3% during the third quarter. Jane Street Group LLC now owns 47,432 shares of the specialty chemicals company’s stock worth $6,046,000 after purchasing an additional 26,568 shares during the period. Natixis Advisors LLC purchased a new stake in Hawkins during the third quarter worth about $2,495,000. FMR LLC grew its position in shares of Hawkins by 20.9% during the third quarter. FMR LLC now owns 256,245 shares of the specialty chemicals company’s stock worth $32,663,000 after buying an additional 44,351 shares in the last quarter. Thrivent Financial for Lutherans grew its position in shares of Hawkins by 86.8% during the third quarter. Thrivent Financial for Lutherans now owns 29,507 shares of the specialty chemicals company’s stock worth $3,761,000 after buying an additional 13,709 shares in the last quarter. Finally, Barclays PLC increased its stake in shares of Hawkins by 180.1% during the third quarter. Barclays PLC now owns 39,728 shares of the specialty chemicals company’s stock worth $5,064,000 after buying an additional 25,545 shares during the period. 69.71% of the stock is currently owned by hedge funds and other institutional investors.

Hawkins Stock Performance

Shares of HWKN stock opened at $105.77 on Friday. The company has a market cap of $2.21 billion, a P/E ratio of 26.98, a PEG ratio of 3.80 and a beta of 0.77. The firm has a fifty day moving average price of $109.41 and a 200 day moving average price of $119.07. The company has a current ratio of 2.50, a quick ratio of 1.53 and a debt-to-equity ratio of 0.23. Hawkins, Inc. has a 12 month low of $71.98 and a 12 month high of $139.55.

Hawkins (NASDAQ:HWKNGet Free Report) last released its quarterly earnings data on Wednesday, January 29th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.77 by ($0.05). Hawkins had a return on equity of 18.95% and a net margin of 8.60%. Sell-side analysts predict that Hawkins, Inc. will post 4 earnings per share for the current fiscal year.

Hawkins Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a dividend of $0.18 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $0.72 dividend on an annualized basis and a yield of 0.68%. Hawkins’s payout ratio is currently 18.37%.

Analysts Set New Price Targets

Separately, BWS Financial reiterated a “neutral” rating and issued a $122.00 price target on shares of Hawkins in a research note on Friday, January 31st.

Check Out Our Latest Report on HWKN

About Hawkins

(Free Report)

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Read More

Institutional Ownership by Quarter for Hawkins (NASDAQ:HWKN)

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.